HyperScribe™ T7 High Yield RNA Synthesis Kit
HyperScribe™ T7 High Yield RNA Synthesis Kit performs in vitro RNA transcription experiment in a relatively short time using T7 RNA polymerase. The kit is designed for high yields of RNA transcripts, highly specific radiolabeled RNA probes and to obtain capped, dye-labeled or biotinylated RNA incorporated modified nucleotides.
RNA synthesized using this kit covers a wide range of applications, such as in vitro translation, antisense RNA and RNAi experiments, RNA vaccines, RNA structure and function studies, ribozyme biochemistry, RNase protein experiments and probe-based hybridization blots.
The kit contains sufficient reagents to carry out 25/50/100 reactions, 20 μL each time. Up to ~50 μg of RNA can be generated with 1 μg of control template per standard reaction. An upgraded version of this product is available with higher yield (~100ug), please check out K1401 HyperScribe™ T7 High Yield RNA Synthesis Kit Plus for more details.

Figure 1: Transcription using T7 RNA Polymerase

Figure 2: PCR primer design for T7 RNA Polymerase template
- 1. Qiming Jiang, Nan Lu, et al. "Targeting LINC02613 to inhibit oral squamous cell carcinoma metastasis and progression via the rehabilitation of LCP1 ubiquitination." Cellular Signalling Volume 138, February 2026, 112253
- 2. Han Xu, Longbin He, et al. "Prunin inhibits Senecavirus A replication through the internal ribosome entry site in vivo and in vitro." Journal of Integrative Agriculture Available online 22 May 2026
- 3. Yanqiu Wang, Lu Tan, et al. "Targeting the ROS-ferroptosis-inflammation cycle with a nanozyme-functionalized hydrogel for intervertebral disc repair." Nat Commun. 2025 Nov 20;16(1):11253. PMID: 41266366
- 4. Yun Xie, Chuanchuan Zhou, et al. "Nicotinamide boosts oocyte quantity and quality by promoting N4-acetylation modification in lupus mice." Sci Adv. 2025 Jul 18;11(29):eadu0955. PMID: 40680131
- 5. Ye Li, Jian Li, et al. "Catalytic-state structure of Candidatus Hydrogenedentes Cas12b revealed by cryo-EM studies." Nucleic Acids Res. 2025 Jun 20;53(12):gkaf519. PMID: 40539514
- 6. Yuchen Song, Chaoyang Guan, et al. "A novel CRISPR - Cas9 nickase - mediated rolling circle amplification (CRIRCA) technique for gene identification and quantitative analysis of extrachromosomal DNA." J Adv Res. 2025 Apr 22:S2090-1232(25)00275-9. PMID: 40274228
- 7. Wang Jiahui, Yu Xiang, et al. "The mitochondrial DNAJC co-chaperone TCAIM reduces α-ketoglutarate dehydrogenase protein levels to regulate metabolism." Molecular Cell Volume 85, Issue 3P638-651.E9, February 06, 2025. PMID: 39889707
- 8. Jiyu Zhang, Liaoyuan Zhang, et al. "Helicase protein DDX11 as a novel antiviral factor promoting RIG-I-MAVS-mediated signaling pathway." mBio. 2024 Oct 29:e0202824. PMID: 39470258
- 9. Irina Palacín-Aliana, Noemí García-Romero, et al. "ddPCR Overcomes the CRISPR-Cas13a-Based Technique for the Detection of the BRAF p. V600E Mutation in Liquid Biopsies." Int J Mol Sci. 2024 Oct 10;25(20):10902. PMID: 39456686
- 10. Nan Lu, Qiming Jiang, et al. "LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway." J Exp Clin Cancer Res. 2024 Sep 30;43(1):267. PMID: 39343925
- 11. Yue Wang, Yatu Peng, et al. "Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis." Sci Rep. 2024 Apr 6;14(1):8095. PMID: 38582932
- 12. Mingzhu Gao, Yan Li, et al. "Targeted mRNA Nanoparticles Ameliorate Blood−Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization." ACS Nano. 2024 Jan 30;18(4):3260-3275. PMID: 38227975
- 13. Mingzhu Gao, Maoping Tang, et al. "Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis." ACS Nano. 2023 Sep 26;17(18):17721-17739. PMID: 37669404
- 14. Yu Z, Wu Z, et al. "Structural basis of a two-step tRNA recognition mechanism for plastid glycyl-tRNA synthetase." Nucleic Acids Research, 2023, 51(8): 4000-4011. PMID: 36912079
- 15. Jingjing Zhang, Yun Li, et al. "Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis." J Exp Clin Cancer Res. 2022 Jan 15;41(1):24. PMID: 35033172
- 16. Han Cao, Yunfei Wang, Ning Luan. "Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy." Vaccines (Basel). 2021 Dec 7;9(12):1440. PMID: 34960186
- 17. Yuting Xiang, Chuanchuan Zhou, et al. "NAT10-Mediated N4-Acetylcytidine of RNA Contributes to Post-transcriptional Regulation of Mouse Oocyte Maturation in vitro." Front Cell Dev Biol. PMID: 34395433
- 18. Cecilia Martinez Campos, Kevin Tsai, et al. "Mapping of pseudouridine residues on cellular and viral transcripts using a novel antibody-based technique." RNA. 2021 Nov;27(11):1400-1411. PMID: 34376564
Quality Control & DataSheet
- View current batch:
| Components | 25 rxns | 50 rxns | 100 rxns |
| T7 RNA Polymerase Mix | 50 μL | 100 μL | 200 μL |
| 10X Reaction Buffer | 50 μL | 100 μL | 200 μL |
| ATP (20 mM) | 50 μL | 100 μL | 200 μL |
| GTP (20 mM) | 50 μL | 100 μL | 200 μL |
| UTP (20 mM) | 50 μL | 100 μL | 200 μL |
| CTP (20 mM) | 50 μL | 100 μL | 200 μL |
| Control Template(0.5 μg/μL) | 5 μL | 10 μL | 20 μL |
| RNase-free H2O | 0.5 mL | 1 mL | 2 x 1 mL |
Store all the kit components at -20°C. | |||
1. Q: RNA fragment size larger than expected?
A: Possible causes: ① Incomplete linearization of plasmid template; ② 3′-overhang on sense strand; ③ Undenatured secondary structure of RNA.
Verify template construction and switch from agarose gel to denaturing gel for RNA detection.
2. Q: RNA fragment size smaller than expected?
A: Possible causes: ① The template carries intrinsic T7-like termination sequences; ② High GC content induces stable secondary structures; ③ RNase contamination.
Different RNA polymerases recognize distinct terminators; switch polymerase if premature termination occurs. Add SSB protein to improve yields for high-GC templates. Analyze samples via denaturing gel electrophoresis for verification.
3. Q: Smearing bands during electrophoresis?
A: Possible causes: ① RNase contamination during handling; ② RNase contamination of DNA template.
The RNase inhibitor included in kit only blocks trace nuclease. Repurify template DNA, use RNase-free pipette tips and tubes, wear disposable gloves and masks, and prepare all solutions with RNase-free water.
4. Q: Can sequences downstream of poly-T termination site on template be transcribed?
A: Hairpin structures hamper transcription, while poly-T sequence barely affects transcription efficiency.
5. Q: Is double-stranded template mandatory?
A: Only the T7 promoter region needs to be double-stranded.
6. Q: Methods for RNA purification? Any matched spin column kit?
A: Purify with RNA Clean and Concentrator Kit (K1069). Use Oligo (dT)25 Beads (K1306/K1307) for poly(A)-tailed mRNA purification.
7. Q: Available linearization methods for plasmid DNA?
A: Restriction digestion (avoid restriction enzymes generating 3′ overhang); PCR amplification (introduce T7 promoter and polyA sequence via forward/reverse primers if absent in original template).
8. Q: Why choose blunt-end or 5′-overhang restriction enzymes for plasmid linearization?
A: Circular unlinearized plasmid enables endless rolling-circle transcription, leading to heterogeneous RNA products. Improper 3′-overhang linearization causes the same issue.
9. Q: Fuzzy sgRNA bands?
A: ~100 nt single-stranded sgRNA readily forms secondary structure in aqueous solution and shifts in mobility. Quick freezing or formamide denaturing PAGE improves separation.
10. Q: Applicable RNA size range for in vitro transcription kit?
A: From ~100 nt sgRNA up to 10 kb long transcripts.
11. Q: How is the transcription efficiency for long and short RNA fragments?
A: Long transcripts usually produce smeared bands, as RNA polymerase tends to dissociate from long templates; this phenomenon is common across similar commercial kits. Templates shorter than 300 nt inhibit transcription initiation due to insufficient time for polymerase-promoter binding. For short templates, increase template dosage to 2 μg and extend incubation to 16 h overnight.
12. Q: How to improve yield for templates with high-GC or stem-loop secondary structures?
A: Raise reaction temperature; supplement SSB protein for abundant complex structures.
13. Q: How to improve yield when template contains T7-like terminator stem-loops?
A: Reduce incubation temperature.
14. Q: Comparison of common RNA purification methods
A: Phenol/chloroform extraction: Low cost but residual free nucleotides remain.
Spin column: Complete removal of free nucleotides at higher cost.
Gel extraction: Highest homogeneity of final RNA product.
Magnetic bead: Fast operation with >90% recovery efficiency.
15. Q: Low transcription yield troubleshooting
A: (1) For transcripts <300 nt: Increase template input to 2 μg and prolong reaction time.
(2) Positive control template (~1000 bp): Take 5–10 μL aliquot after 2 h incubation for yield test; continue remaining reaction to match experimental incubation duration.
(3) RNA loss varies with different purification protocols.
(4) Repurify DNA template.
(5) Confirm template concentration and integrity.
(6) Test alternative promoters and RNA polymerases.
16. Q: Do NTP or DNase amounts need adjustment when template is increased to 2 μg?
A: NTP dosage remains unchanged. To ensure complete template digestion, increase DNase from 1 μL to 3 μL if required.
17. Q: RNA yield from 0.5 μg control template?
A: The control template is ~1000 bp. With 0.5 μg input, the yield ranges from 50 to 150 μg depending on original or upgraded kit versions.
18. Q: Function of three consecutive GGG downstream of TATA in T7 promoter?
A: The GGG motif improves transcription efficiency.
19. Q: Is RNase inhibitor premixed in the kit components?
A: T7 RNA Polymerase Mix is pre-supplemented with RNase inhibitor and pyrophosphatase. The inhibitor only suppresses trace RNase; strict RNase-free operation is required throughout experiments.


















